Small Trial Shows Patients Controlled HIV Without Daily Meds For Months
TUESDAY, Dec. 2, 2025 A small but closely watched study is giving researchers new optimism in the search for long-term HIV control, and possibly a cure.For the
STAT+: Top drug regulator Richard Pazdur set to leave the FDA
WASHINGTON — Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration at the end of this month, adding to the turmoil atop the agency. Pazdur
IMCD announces new global leader for Business Group Food & Nutrition
Emmanuel Colette to assume global leadership role as Marc van Gerwen prepares for retirement
With eye on supply chain resilience and domestic production, EU nudges closer to drug shortage prevention framework
Tuesday, the European Council gathered behind new regulations that seek to diversify local biopharma supply chains, support collaborative drug procurement models and devise incentives to bolster drug production in the bloc.
Global Plant Nutrition Company Launches CANNA AGRI Solutions To Support Commercial-Scale Cultivation
ARCADIA, Calif., December 02, 2025–CANNA, the global experts in plant nutrition and substrate synergy, today announced the launch of CANNA AGRI Solutions, a new commercial product category designed to support large-scale cultivation
WHO Issues First Guidance on Using GLP-1 Drugs to Treat Obesity
TUESDAY, Dec. 2, 2025 The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects
OhioHealth Deploys NetMenu to Standardize Patient Nutrition Across 16 Hospitals
SCOTTSDALE, Ariz. & COLUMBUS, Ohio, December 02, 2025–OhioHealth adopts Transact + CBORD’s NetMenu across 16 hospitals to standardize patient nutrition, streamline meal ordering, and enhance patient care.
Days before ACIP meeting, committee chair gets a new job at HHS
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. You have a few days left to get the extended Cyber Monday deal on STAT+.
Expert review finds delaying the hepatitis B vaccine birth dose would increase chronic infections in kids
Delaying the timing of vaccinating infants against hepatitis B — an idea a federal vaccine advisory group will likely vote on later this week — would neither improve the effectiveness of the vaccine